Study shows Merck’s Januvia does not increase heart risks; a former Genentech exec launches a behavioral health business; lawmakers want black-box warnings on more opioids
Five things for pharma marketers to know, Thursday, June 4
Employer-insured enrollees spend more on prescriptions than health-insurance exchange enrollees, but the groups spend the same amount of money when it comes to specialty medications, a study shows.
A House committee is looking into the FDA’s warning letter publication process; Amgen and Roche collaborate on cancer combination drug; study shows online health information fails teenagers
Five things for pharma marketers to know: Thursday, May 28
The FBI is investigating Johnson & Johnson’s morcellator; Sanofi purchased another priority review voucher; generic drug prices are falling at a slow rate